Old Web
English
Sign In
Acemap
>
authorDetail
>
Luis Paz-Arez
Luis Paz-Arez
General surgery
Oncology
Erlotinib
Internal medicine
Medicine
2
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P3.02b-045 Patritumab plus Erlotinib in EGFR Wild-Type Advanced Non–Small Cell Lung Cancer (NSCLC): Part a Results of HER3-Lung Study: Topic: EGFR Clinical
2017
Journal of Thoracic Oncology
Luis Paz-Arez
Piotr Serwatowski
A. Szczesna
Joachim von Pawel
Luca Toschi
Csőszi Tibor
Alessandro Morabito
Ling Zhang
Dale Shuster
Shuquan Chen
Catherine Copigneaux
Wallace Akerley
Show All
Source
Cite
Save
Citations (8)
Economic analysis of first-line treatment with erlotinib in an EGFR-mutated population with advanced NSCLC
2016
Journal of Thoracic Oncology
A. Vergnenegre
Bartomeu Massuti
Filippo De Marinis
Enric Carcereny
Enriqueta Felip
Pascal Dô
Jose Miguel Sanchez
Luis Paz-Arez
C. Chouaid
Rafael Rosell
Show All
Source
Cite
Save
Citations (15)
1